News & Updates

Lipoprotein(a) molar concentrations help inform cardiovascular risk
Lipoprotein(a) molar concentrations help inform cardiovascular risk
19 Feb 2022

The risk of coronary artery disease (CAD) can be predicted by a single accurate measurement of lipoprotein(a) molar concentration if therapies substantially altering lipoprotein(a) are not present, suggests a recent study.

Lipoprotein(a) molar concentrations help inform cardiovascular risk
19 Feb 2022
Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF
Edoxaban effectively keeps D-dimer low in patients with NVAF, AHF
19 Feb 2022
Tirofiban may improve outcomes in LAA strokes
Tirofiban may improve outcomes in LAA strokes
16 Feb 2022 byAudrey Abella

While additional tirofiban prior to endovascular treatment (EVT) did not appear to benefit stroke patients with large vessel occlusion (LVO), it did seem to have an advantage for those with large artery atherosclerosis (LAA), findings from the RESCUE BT trial have shown.

Tirofiban may improve outcomes in LAA strokes
16 Feb 2022